Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Zhejiang Garden Bio-chemical High-tech Co Ltd
Accrued Liabilities
Zhejiang Garden Bio-chemical High-tech Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SZSE:300401
|
Accrued Liabilities
¥28.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
23%
|
CAGR 10-Years
21%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Accrued Liabilities
¥137.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Accrued Liabilities
¥2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
21%
|
CAGR 10-Years
23%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Accrued Liabilities
¥787.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
15%
|
CAGR 10-Years
21%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Accrued Liabilities
¥187.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
Glance View
Zhejiang Garden Bio-chemical High-tech Co Ltd, nestled in the economic heart of China, boasts a robust presence in the global vitamin industry. Established with a keen focus on biosynthesis, the company has carved a niche for itself by specializing in the production of Vitamin D3. As a key player in the vitamin sector, Garden Bio-chemical uses advanced biotechnological methods to convert raw materials such as lanolin, derived from sheep's wool, into highly purified Vitamin D3. This complex process involves carefully monitored steps of extraction and fermentation, ensuring the production of high-quality vitamins that meet stringent international standards. The company’s financial health is intricately tied to its ability to meet the rising demand for vitamins across diverse markets, particularly in health-conscious segments. With the growing global emphasis on nutrition and wellness, Garden Bio-chemical capitalizes on this trend by enhancing its production capabilities and expanding its market reach. The company's revenue model relies heavily on large-scale contracts with pharmaceutical companies, dietary supplement manufacturers, and other sectors that require consistent and reliable supplies of Vitamin D3. By maintaining strong relationships with its clients and continuing to innovate in its production processes, Zhejiang Garden Bio-chemical High-tech Co Ltd ensures sustainability and profitability in an increasingly competitive market.
See Also
What is Zhejiang Garden Bio-chemical High-tech Co Ltd's Accrued Liabilities?
Accrued Liabilities
28.5m
CNY
Based on the financial report for Sep 30, 2025, Zhejiang Garden Bio-chemical High-tech Co Ltd's Accrued Liabilities amounts to 28.5m CNY.
What is Zhejiang Garden Bio-chemical High-tech Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
21%
Over the last year, the Accrued Liabilities growth was 39%. The average annual Accrued Liabilities growth rates for Zhejiang Garden Bio-chemical High-tech Co Ltd have been 16% over the past three years , 23% over the past five years , and 21% over the past ten years .